arrow
M

Marc Schmalzing

University Hospital Wurzburg
H指数:32
被引数:4,620

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Phenotypes, Treatment, and Outcomes of Rheumatic Immune–Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitors: A Rheumatologists-Referred Multicenter German Registry Cohort

风湿性免疫相关不良事件的临床表型、治疗和结局:一项风湿科医师转诊的多中心德国登记研究队列

2026-09-210
OAAI
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosis

系统性硬化病相关肺动脉高压合并或不合并间质性肺疾病的治疗及其对生存的影响:德国系统性硬化病网络的大规模队列研究

2026-04-150
OA
[18F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritis

[18F]-FDG-PET/CT可检测巨细胞动脉炎中的亚临床视神经炎症

2026-03-180
OAAI
Calprotectin and serum amyloid A for disease activity assessment in giant cell arteritis and polymyalgia rheumatica: results from a prospective single-centre cohort study

钙卫蛋白和血清淀粉样蛋白A在巨细胞动脉炎和风湿性多肌痛疾病活动性评估中的应用:一项前瞻性单中心队列研究的结果

2026-03-040
PRE
High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: an open-label, non-inferiority phase 2 trial

大剂量化疗和自体CD34选择性干细胞移植治疗进行性系统性硬化症的心脏和肺部表现调整: 开放标签,非劣效性2期试验

2026-01-290
OAAI
The influence of baseline aortitis on aortic dilation risk in GCA: a multicentre imaging study

基线主动脉炎对巨细胞动脉炎患者主动脉扩张风险的影响:一项多中心影像学研究

2025-12-010
PRE
S2k guidelines on diagnostics and treatment of systemic sclerosis Full version

S2k指南:系统性硬化症的诊断与治疗(完整版)

2025-11-010
PRE
S2k guideline Diagnosis and therapy of systemic sclerosis Summary

S2k指南:系统性硬化症的诊疗概要

2025-11-010
PRE
Renewed increase in new Janus kinase inhibitor prescriptions Analysis of the German RHADAR registry

新JAK抑制剂处方的再次增加:德国RHADAR注册研究分析

2025-09-010
OAAI
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee

自体造血干细胞移植治疗风湿性疾病:EBMT实践协调与指南委员会的最佳实践建议

2025-08-200
OAAI
Diverging effects of tumor necrosis factor inhibitors and conventional synthetic disease-modifying antirheumatic drugs on immunosenescence and inflammageing in rheumatoid arthritis: a cross-sectional analysis

肿瘤坏死因子抑制剂和传统合成改善病情抗风湿药物对类风湿关节炎免疫衰老和炎症衰老的差异化影响:一项横断面分析

2025-05-220
OA